Lyka Labs Ltd

LYKALABS Stock View

(NSE)

144.25

407.83
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Lyka Labs Ltd stands at 7 against 8, three months back.

Lyka Labs Limited is an India-based company that is engaged in the business of pharmaceutical and related activities, including research. The Company is focused on the manufacturing of pharmaceutical formulations and active pharmaceutical ingredients (APIs) across various therapeutic segments. It has developed various products in the product categories, such as injectables, including liquid injections, lyophilized injections in antibacterial, antifungal, NSAIDS, proton pump inhibitors and anesthetics; and topical preparations, such as ointments/creams and lotions. It offers formulations, such as emollient, topical steroid, pain killer, topical steroid with keratolytic, topical steroid with antifungal, cleansing lotion, anti-dandruff shampoo, hair care products, sunscreen, muscle relaxant and bone resorption inhibitor, among others. It also provides manufacturing services to pharmaceutical companies. Its subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
131.51
100 DMA ()
131.78
200 DMA ()
136.85
52 Weeks Range
102.10
267.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp